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Introduction
The steroid hormone androgen mediates a wide range
of developmental, physiological and malignant responses
by acting as a ligand for the androgen receptor (AR).
AR in turn functions as a nuclear receptor transcription
factor and executes specific gene expression programs
in an androgen-dependent manner. Since the growth of
prostate cancer cells initially depends on androgen, can-
cer therapy uses hormone-deprivation approaches to
reduce the levels of serum androgen. While prostate
cancer (PC) initially responds to androgen-ablation,
most tumors progress to a castration resistant (CR) state
insensitive to treatment. Both the androgen-dependent
and the CRPC state depend on AR, which is probably
activated by alternative molecular pathways in CRPC in
response to low androgen levels.
Methods and results
Here, we assess the role of the transcriptional co-regula-
tor TRIM24/TIF1a in mediating AR-dependent gene
expression and growth. We find that TRIM24 expres-
sion is increased in different states of PC, particularly in
CRPC. When we induce the drug-regulated knock-down
of TRIM24, we find that cell growth in both our andro-
gen-dependent (LNCaP) and in our CRPC model
(LNCaP-abl) is affected. Therefore, we hypothesize that
TRIM24 is involved in mediating both ligand-dependent
and ligand-independent activation of AR. This is further
consistent with our finding that TRIM24 and AR can
physically interact in both conditions. We are currently
identifying TRIM24-dependent gene expression pro-
grams by combining genome-wide binding analyses with
microarray studies.
Discussion
This will help us shed light on how the transcriptional
co-regulator TRIM24 may reprogram AR activity in its
progression from an androgen-dependent to a castra-
tion-resistant state. Current results from this study will
be presented at the meeting.
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